美国 · SEC FORM 4
SOLENO THERAPEUTICS INC
SLNO · — · CIK 0001484565 · Healthcare
内部人信号
当前没有活跃买入信号
0 qualifying P purchase groups
当前 180 天评分窗口
13 同一窗口内观察到的 Form 4 交易行
0 sales · 13 期权、代扣税、授予、赠与或其他交易行
最近一次合资格买入2023-09-28 · EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD · $5.0M
为什么没有活跃信号？
买入活动无
近期买入无
近期卖出无
买入信号状态未激活
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Yen KristenSEE REMARKS
○
Volck BirgitteDirector
○
Sinclair AndrewDirector
○
Pauls MatthewDirector
○
Norrett KevinChief Business Officer
○
Manning MeredithChief Commercial Officer
○
● 买入▼ 卖出○ 其他
Showing the six most active owners; 7 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
暂无已记录的活跃信号快照
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2023-09-28 · EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD.
近期 Form 4 活动
0买入
6卖出
31其他 Form 4 交易行
32SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他13 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
FINRA 报告中没有该股票代码的空头余额。
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2023-09-28 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | Common Stock | 250,000 | USD 20.00 | USD 5,000,000 | SEC 申报 ↗ |
| 2023-09-26 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | Common Stock | 616,789 | USD 16.40 | USD 10,113,916 | SEC 申报 ↗ |
| 2023-06-06 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | Common Stock | 200 | USD 5.93 | USD 1,186 | SEC 申报 ↗ |
| 2023-06-05 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | Common Stock | 78,468 | USD 5.98 | USD 469,239 | SEC 申报 ↗ |
| 2023-06-02 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | Common Stock | 64,630 | USD 5.93 | USD 383,256 | SEC 申报 ↗ |
| 2023-06-01 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | Common Stock | 7,500 | USD 5.59 | USD 41,925 | SEC 申报 ↗ |
| 2023-05-31 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | Common Stock | 10,000 | USD 5.28 | USD 52,800 | SEC 申报 ↗ |
| 2023-05-30 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | Common Stock | 17,500 | USD 5.34 | USD 93,450 | SEC 申报 ↗ |
| 2023-05-26 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | 210859 | 22,500 | USD 5.27 | USD 118,575 | SEC 申报 ↗ |
| 2023-05-25 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | 210859 | 37,500 | USD 5.18 | USD 194,250 | SEC 申报 ↗ |
| 2023-05-24 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | 210859 | 25,000 | USD 5.48 | USD 137,000 | SEC 申报 ↗ |
| 2023-05-23 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | Common Stock | 27,500 | USD 5.45 | USD 149,875 | SEC 申报 ↗ |
| 2023-05-22 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | Common Stock | 27,300 | USD 5.12 | USD 139,776 | SEC 申报 ↗ |
| 2023-05-19 | EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 买入 (P) | Common Stock | 25,200 | USD 4.62 | USD 116,424 | SEC 申报 ↗ |
| 2022-03-31 | SCHULER JACK W | 买入 (P) | Common Stock | 4,000,000 | USD — | USD — | SEC 申报 ↗ |
Form 4 申报证据
37 transaction lines in the latest 365-day window; 464 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Yen Kristen | D (D) | Common Stock | 37,639 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-18 | Volck Birgitte | D (D) | Common Stock | 17,536 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-18 | Sinclair Andrew | D (D) | Common Stock | 10,491 | USD — | USD — | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Yen Kristen | D (D) | Common Stock | 37,639 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-18 | Volck Birgitte | D (D) | Common Stock | 17,536 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-18 | Sinclair Andrew | D (D) | Common Stock | 10,491 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-18 | Pauls Matthew | D (D) | Common Stock | 10,491 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-18 | Norrett Kevin | D (D) | Common Stock | 17,786 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-18 | Manning Meredith | D (D) | Common Stock | 64,507 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-18 | Joshi Manher | D (D) | Common Stock | 20,171 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-18 | Huang Michael F. | D (D) | Common Stock | 39,823 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-18 | Hirano Patricia C | D (D) | Common Stock | 22,702 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-18 | Hahn Mark W | D (D) | Common Stock | 10,046 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-18 | Fulk Jennifer | D (D) | Common Stock | 39,200 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-18 | Bir Dawn Carter | D (D) | Common Stock | 16,991 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-18 | Anish Bhatnagar | D (D) | Common Stock | 583,656 | USD — | USD — | SEC 申报 ↗ |
| 2026-03-27 | Manning Meredith | 卖出 (S) | Common Stock | 7,522 | USD 30.44 | USD 228,998 | SEC 申报 ↗ |
| 2026-03-27 | Huang Michael F. | 卖出 (S) | Common Stock | 6,582 | USD 30.44 | USD 200,381 | SEC 申报 ↗ |
| 2026-03-02 | Fulk Jennifer | 奖励／授予 (A) | Common Stock | 39,200 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-21 | Yen Kristen | 奖励／授予 (A) | Common Stock | 10,400 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-21 | Norrett Kevin | 奖励／授予 (A) | Common Stock | 3,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-21 | Manning Meredith | 奖励／授予 (A) | Common Stock | 28,600 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-21 | Mackaness James H | 奖励／授予 (A) | Common Stock | 28,600 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-21 | Joshi Manher | 奖励／授予 (A) | Common Stock | 4,100 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-21 | Huang Michael F. | 奖励／授予 (A) | Common Stock | 10,400 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-21 | Hirano Patricia C | 奖励／授予 (A) | Common Stock | 10,400 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-01-21 | Anish Bhatnagar | 奖励／授予 (A) | Common Stock | 114,200 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-12-15 | Yen Kristen | 代扣税 (F) | Common Stock | 904 | USD 49.95 | USD 45,155 | SEC 申报 ↗ |
| 2025-12-15 | Manning Meredith | 代扣税 (F) | Common Stock | 1,922 | USD 49.95 | USD 96,004 | SEC 申报 ↗ |
| 2025-12-15 | Mackaness James H | 代扣税 (F) | Common Stock | 2,013 | USD 49.95 | USD 100,549 | SEC 申报 ↗ |
| 2025-12-15 | Huang Michael F. | 代扣税 (F) | Common Stock | 812 | USD 49.95 | USD 40,559 | SEC 申报 ↗ |
| 2025-12-15 | Hirano Patricia C | 代扣税 (F) | Common Stock | 904 | USD 49.95 | USD 45,155 | SEC 申报 ↗ |
| 2025-12-15 | Anish Bhatnagar | 赠与 (G) | Common Stock | 100,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | SLNO |
| CIK | 0001484565 |
| 行业 | Healthcare |
| 细分行业 | — Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | — |
数据覆盖
| 本地 Form 4 历史 | 464 transaction lines from 2020-01-22 to 2026-05-18 41 P purchase lines · 275 S sale lines · 148 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.